DHANLYRA

Anti-inflammatories; Cardiovascular pharmaceuticals; Pharmaceutical preparations for the treatment and prevention of inflammatory diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment and prevention of cardiac diseases and disorders; Pharmaceutical preparations for the treatment and prevention of immune-mediated diseases and disorders;; Pharmaceutical preparations for the treatment and prevention of rare diseases and disorders